(Guest Lecture): August 2022 The Role Of Maintenance Therapy after SCT

(Guest Lecture): August 2022 The Role Of Maintenance Therapy after SCT
Myeloma Determination Study | Paul Richardson, MD | IMS 2022
SARCLISA® (isatuximab) Update | Paul Richardson, MD | IMS 2022
REGN5458 Bispecific Antibody | Naresh Bumma, MD | IMS 2022
Fit Vs. Frail & Smoldering Myeloma | María-Victoria Mateos, MD, PhD | IMS 2022
(Guest Lecture): May 2022 - Translating Ideas Into Treatment - Dickran Kazandjian, MD